摘要
背景:苯抑素及其衍生物对多种临床前肿瘤模型显示出显著的抗增殖活性。苯妥英的结构简单和优良稳定性NS为开发具有深刻抗核活性和优良细胞毒性的各种衍生物提供了一个刺激的前提。 目的:研究苯甲酸抑制素衍生物通过微管秋水仙碱结合位点抑制微管蛋白聚合,阻滞G2/M期的文献。f细胞周期。此外,苯抑素衍生物作为血管靶向/干扰剂正在进行临床评价,并显示出直接的抗血管生成特性。 方法:使用有重点的审查问题和包含/排除标准,对同行评审的研究文献进行有组织、精心设计和适当管理的书目数据库搜索。已经为这篇文章做过了。 结论:本文综述了苯抑素类化合物的合成及其结构活性关系,并对环A、环B和酮类化合物进行了修饰。从药物化学的角度对其定位进行了探讨,得出了正确的结论。
关键词: 结构-活性关系,细胞毒性活性,抗核活性,微管蛋白聚合抑制,秋水仙素结合位点,苯他汀。
Current Medicinal Chemistry
Title:Recent Developments on Phenstatins as Potent Antimitotic Agents
Volume: 25 Issue: 20
关键词: 结构-活性关系,细胞毒性活性,抗核活性,微管蛋白聚合抑制,秋水仙素结合位点,苯他汀。
摘要: Background: Phenstatin and their derivatives display remarkable antiproliferative activity toward a wide variety of preclinical tumor models. Structural simplicity and excellent stability of phenstatins offer a stimulating premise for developing various derivatives with profound antimitotic activity and excellent cytotoxicity.
Objective: To do analysis of literature that phenstatins derivatives inhibit tubulin polymerization through their interaction at the colchicine binding site of microtubules and arrest the G2/M phase of the cell cycle. In addition, phenstatin derivatives are undergoing clinical evaluation as vascular targeting/disrupting agents and also exhibit direct antiangiogenic properties.
Methods: An organised well designed and appropriately managed search of bibliographic databases for peer-reviewed research literature using a focused review question and inclusion/ exclusion criteria has been done for this article.
Conclusion: In this review article, the synthesis and structure-activity relationships of phenstatin and a wide number of their reported analogues with modifications to ring A, ring B, and to the keto position are discussed in the perspective of medicinal chemistry with proper conclusion.
Export Options
About this article
Cite this article as:
Recent Developments on Phenstatins as Potent Antimitotic Agents, Current Medicinal Chemistry 2018; 25 (20) . https://dx.doi.org/10.2174/0929867324666171106162048
DOI https://dx.doi.org/10.2174/0929867324666171106162048 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemical and Bioactive Diversities of the Genus Chaetomium Secondary Metabolites
Mini-Reviews in Medicinal Chemistry TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Potential Candidate for Combined Treatment of Hematological Malignancies
Current Pharmaceutical Design Functional Multipotency of Stem Cells: A Conceptual Review of Neurotrophic Factor-Based Evidence and Its Role in Translational Research
Current Neuropharmacology Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells
CNS & Neurological Disorders - Drug Targets The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy
Current Drug Targets Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Flavonoids as Sirtuin Modulators
Current Topics in Medicinal Chemistry Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry Radiobromine-Labelled Tracers for Positron Emission Tomography: Possibilities and Pitfalls
Current Radiopharmaceuticals Role of Alterations in the Apoptotic Machinery in Sensitivity of Cancer Cells to Treatment
Current Pharmaceutical Design ER Stress and Autophagy
Current Molecular Medicine Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer’s Disease
Current Alzheimer Research Parkinsons Disease: Genetics and Beyond
Current Neuropharmacology Voltage-Gated Calcium Channels as Targets for the Treatment of Chronic Pain
Current Drug Targets - CNS & Neurological Disorders Combined Chemotherapy or Biotherapy with Jasmonates: Targeting Energy Metabolism for Cancer Treatment
Current Pharmaceutical Biotechnology Biological Responses to Hydrogen Molecule and its Preventive Effects on Inflammatory Diseases
Current Pharmaceutical Design Roles of EGFR, PI3K, AKT, and mTOR in Heavy Metal-Induced Cancer
Current Cancer Drug Targets Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Current Molecular Medicine Selective Toxicity of Apigenin on Cancerous Hepatocytes by Directly Targeting their Mitochondria
Anti-Cancer Agents in Medicinal Chemistry Serotonin Receptors of Type 6 (5-HT6): From Neuroscience to Clinical Pharmacology
Current Medicinal Chemistry